References
Note: Links to citations open in a new browser window.  To return to this page, just close the newly opened browser window by clicking on the X in the upper right hand corner of the window.

  1. White DJ. Dental calculus: recent insights into occurrence, formation, prevention, removal and oral health effects of suprangingival and subgingival deposits. Eur J Oral Sci 1997;105: 508-522.

  2. White DJ. Tartar control dentifrices: current status and future prospects. In: Embery G, Rolla G, editors. Clinical and Biological Aspects of Dentifrices. Oxford: Oxford University Press, 1992: 277-291.

  3. Rustogi KN, Triratana T, Lindhe J, Kietprajuk C, Volpe AR. The association between supragingival calculus deposits and the extent of gingival recession in a sample of Thai children and teenagers. J Clin Dent 1991; 6-11.

  4. Mallatt ME, Beiswanger BB, Swancar JR, Stookey GK, Hennon DK. Influence of soluble pyrophosphate on calculus formation in adults. J Dent Res 1985;64: 1159-1162.

  5. Zacherl WA, Pfeiffer HJ, Swancar JR. The effect of soluble pyrophosphates on dental calculus in adults. J Am Dent Assoc 1985;110: 737-738.

  6. Hagmann M. A gene for smooth running joints. Science 2000; 289:226-227.

  7. White DJ. Processes contributing to the formation of dental calculus. Biofouling 1991;4: 209-218.

  8. Rowles SL. Composition of supragingival calculus. J Dent Res 1967;46: 114-119.

  9. White DJ, Bowman WD, Nancollas GH. Physical chemical aspects of dental calculus formation and inhibition: in vitro and in vivo. In: ten Cate J, editor. Recent Advances in the Study of Dental Calculus. 1989: 175-188.

  10. Sammons MC, Coombs MA, Deibel RM, Collier WG, McCormack L, White DJ. Dentifrice effects on uptake and retention of pyrophosphate in plaque. J Dent Res 1989;68: 421 Abstract.

  11. Adams D. Calculus inhibition agents: A review of recent clinical trials. Adv Dental Res 1995;9: 410-418.

  12. Stookey GK, Jackson RJ, Beiswanger BB, Stookey KR. Clinical efficacy of chemicals for calculus prevention. In: ten Cate J, editor. Recent Advances in the Study of Dental Calculus. Oxford: IRL Press, 1989: 235-258.

  13. Volpe AR, Petrone ME, Davies R. A review of calculus clinical efficacy studies. J Clin Dent 1992; 4: 71-81.

  14. Volpe AR, Manhold JH, Hazen SP. In vivo calculus assessment, part I: a method and its examiner reproducibility. J Periodontol 1965;36: 299-304.

  15. Gaffar A, Polefka T, Afflitto J, Esposito A, Smith S. In vitro evaluations of pyrophosphate/copolymer/NaF as an anticalculus agent. Compend Supplt 1987;Suppl. 8: S242-250.

  16. Rykke M, Rolla G. Desorption of acquired enamel pellicle in vivo by pryophosphate. Scand J Dent Res 1990;98: (3)211-214.

  17. Rolla G, Rykke M, Sonju T. Effect of pyrophosphate on protein adsorption to hydroxyapatite in vitro and on pellicle formation in vivo. Scand J Dent Res 1988;96: 517-522. Abstract.

  18. Kozak KM, White DJ. Dentifrice effects toward chemical stain control: An in vitro comparison. J Dent Res 2000;79: 404 Abstract.

  19. White DJ, Glandorf WM, McClanahan SF, Cox ER, Estes PD. Inventors. Dentifrice compositions containing polyphosphate and fluoride. 1999; (U.S. Patent #5,939,052).

  20. White DJ, Campbell SJ, Hyde JP, Gerlach RW. Novel model for evaluating anticalculus efficacy of tartar control dentifrices. J Dent Res 1999;78: 497 Abstract.

  21. Gerlach RW. Comparative intraoral tolerance of polyphosphate and pyrophosphate antitartar dentifrices. J Dent Res 2000;79: 429 Abstract.
Page 18 of 19